Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda applies for approval of relugolix for uterine fibrosis in Japan

March 7, 2018

New Eli Lilly GPR40 agonist LY-3104607 shows glucose-lowering potential

March 7, 2018

EMA accepts regulatory submission for Forxiga in adults with type 1 diabetes

March 7, 2018

Moogene Medi describes DPP4-targeting cas9 protein and guide RNAs

March 5, 2018

Novel human insulin analogues created at Jiangsu Hengrui Medicine

March 5, 2018

Reata releases data from phase II trial of omaveloxolone in patients with mitochondrial myopathies

March 2, 2018

Merck & Co. patents new CYP8B1 inhibitors

March 2, 2018

Dompe Farmaceutici identifies novel FFAR1 agonists

March 1, 2018

Zafgen presents novel MetAP 2 inhibitors

Feb. 28, 2018

EMA gives accelerated assessment to Shire's lanadelumab

Feb. 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...